Effect of MiniGo as add-on to Oral Laxatives for Children With

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to compare combination therapy with low volume trans anal irrigation (TAI) and oral laxatives to monotherapy with oral laxatives in children with functional constipation and fecal incontinence. The main questions it aims to answer are: - Can more efficient treatment be achieved with aforementioned combination therapy? - Does the well-being of the children change, when they are well treated for their symptoms? - Is low-volume trans anal irrigation a tolerable treatment method for children? Participants will be randomized into 2 groups, where one group is treated with current standard treatment of PEG (oral laxatives), and the other group is treated with PEG + daily low volume TAI.

Clinical Trial Description

Functional constipation and retentive fecal incontinence is a prevalent health issue in children. The current standard treatment regimen in Denmark consists mainly of behavioral interventions and oral laxative treatment. This treatment leaves a large group of non-responders. Suffering from constipation and fecal incontinence has a negative impact on well-being in children, wherefore treatment of this condition should be improved. Earlier literature shows that trans anal irrigation (TAI) is an effective means of managing these symptoms, both in children and adults. However, conventional high volume TAI is time consuming (up to 45 minutes-an hour daily) and a cause of discomfort, or even pain. This can lead to low compliance and treatment failure. Low volume TAI has the potential of bringing about all the positive effects of TAI, but with less time consumption (only few minutes daily) and less discomfort. In this clinical trial, we will compare how children with functional constipation and fecal incontinence respond to treatment with 1) oral laxatives (PEG) alone versus 2) PEG and low volume TAI with the MiniGo-irrigation system. The intervention period is 6 weeks, and the treatment takes place at home. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05570318
Study type	Interventional
Source	University of Aarhus
Contact	Luise Borch, MD, phd
Phone	+4578430389
Email	luise.borch@rm.dk
Status	Recruiting
Phase	N/A
Start date	November 1, 2022
Completion date	January 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04506801` - The Effect of Probiotics on Functional Constipation in the Elderly	N/A
Completed	`NCT04620161` - A Proof of Concept Study of Pradigastat in Patients With Functional Constipation	Phase 2
Active, not recruiting	`NCT02361749` - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation	Phase 4
Completed	`NCT03054805` - The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation	Phase 4
Not yet recruiting	`NCT01913665` - The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation	N/A
Completed	`NCT01622972` - Mode of Action of Moviprep	Phase 4
Completed	`NCT01348152` - Effect of TU-100 in Patients With Functional Constipation	Phase 2
Completed	`NCT01212146` - Probiotic-enriched Artichoke in Functional Constipation	N/A
Completed	`NCT04231162` - Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation	N/A
Not yet recruiting	`NCT03639142` - Dried Plums (Prunes) vs. Polyethylene Glycol 4000 for Treatment of Functional Constipation in Children	Phase 3
Recruiting	`NCT04918329` - Functional Digestive Disorders Observatory
Completed	`NCT02592200` - Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women	N/A
Completed	`NCT03707002` - Effect of scFOS on Increase in Stool Frequency in Constipated People	N/A
Recruiting	`NCT06083311` - The Efficacy of a Probiotic for Functional Constipation (FC)	N/A
Completed	`NCT04110145` - Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation	Phase 2
Recruiting	`NCT06196073` - Visceral Osteopathy in Functional Constipation	N/A
Active, not recruiting	`NCT04026113` - Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)	Phase 3
Completed	`NCT02359396` - A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics	Phase 1
Completed	`NCT01847950` - Effects of scFOS on Stool Frequency in People With Functionnal Constipation	N/A
Recruiting	`NCT01274793` - Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of MiniGo as add-on to Oral Laxatives for Children With Constipation and Fecal Incontinence

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms